+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Short Bowel Syndrome Market Research Report by Drug Class, Distribution Channel, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4985952
  • Report
  • October 2021
  • Region: Global
  • 195 Pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Short Bowel Syndrome Market is Projected to Reach USD 1,362.81 Million by 2026, Registering a CAGR of 17.71%

FEATURED COMPANIES

  • 9 Meters Biopharma, Inc.
  • Ardelyx Inc.
  • Merck KGaA
  • Novartis International AG
  • Oxthera AB
  • VectivBio AG
The Global Short Bowel Syndrome Market size was estimated at USD 512.32 million in 2020, is expected to reach USD 594.91 million in 2021, and projected to grow at a CAGR of 17.71% reaching USD 1,362.81 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Short Bowel Syndrome to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Drug Class, the market was studied across GLP-2, Glutamine, and Growth Hormone.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies, Online Sales, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Short Bowel Syndrome Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Short Bowel Syndrome Market, including 9 Meters Biopharma, Inc., Adocia SAS, Ardelyx Inc., AstraZeneca PLC, Emmaus Life Sciences, Inc., Merck KGaA, Nestlé S.A., Novartis International AG, OPKO Health, Inc., Oxthera AB, Pfizer Inc., PhaseBio Pharmaceuticals Inc., Sancilio and Company, Inc., Swedish Orphan Biovitrum AB, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., VectivBio AG, Viatris Inc., and Zealand Pharma A/S.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Short Bowel Syndrome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Short Bowel Syndrome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Short Bowel Syndrome Market?
4. What is the competitive strategic window for opportunities in the Global Short Bowel Syndrome Market?
5. What are the technology trends and regulatory frameworks in the Global Short Bowel Syndrome Market?
6. What is the market share of the leading vendors in the Global Short Bowel Syndrome Market?
7. What modes and strategic moves are considered suitable for entering the Global Short Bowel Syndrome Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 9 Meters Biopharma, Inc.
  • Ardelyx Inc.
  • Merck KGaA
  • Novartis International AG
  • Oxthera AB
  • VectivBio AG
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increased Prevalence of Short Bowel Syndrome and Awareness Programs
5.2.2. Rising Efforts in the Launch of Effective Treatments
5.3. Restraints
5.3.1. Lack of Approved Treatment Options and Associated Adverse Complications with Drugs
5.4. Opportunities
5.4.1. Development of Short Bowel Syndrome Drugs is at a Nascent Stage
5.4.2. Public-Private Partnerships are Encouraging Pharmaceutical Companies to Develop New Orphan Drugs for Short Bowel Syndrome
5.5. Challenges
5.5.1. Limited Initial Diagnostic and Availability of Advanced Option

6. Short Bowel Syndrome Market, by Drug Class
6.1. Introduction
6.2. GLP-2
6.3. Glutamine
6.4. Growth Hormone

7. Short Bowel Syndrome Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Sales
7.4. Retail Pharmacies

8. Americas Short Bowel Syndrome Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Short Bowel Syndrome Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Short Bowel Syndrome Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 9 Meters Biopharma, Inc.
12.2. Adocia SAS
12.3. Ardelyx Inc.
12.4. AstraZeneca PLC
12.5. Emmaus Life Sciences, Inc.
12.6. Merck KGaA
12.7. Nestlé S.A.
12.8. Novartis International AG
12.9. OPKO Health, Inc.
12.10. Oxthera AB
12.11. Pfizer Inc.
12.12. PhaseBio Pharmaceuticals Inc.
12.13. Sancilio and Company, Inc.
12.14. Swedish Orphan Biovitrum AB
12.15. Takeda Pharmaceutical Company Limited
12.16. Teva Pharmaceutical Industries Ltd.
12.17. VectivBio AG
12.18. Viatris Inc.
12.19. Zealand Pharma A/S

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Short Bowel Syndrome Market Size, 2020 vs 2026 (USD Million)
Figure 2. Global Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 3. Global Short Bowel Syndrome Market: Market Dynamics
Figure 4. Global Short Bowel Syndrome Market Size, by Drug Class, 2020 vs 2026 (%)
Figure 5. Global Short Bowel Syndrome Market Size, by Drug Class, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for Global Short Bowel Syndrome Market Size, by Drug Class, 2026
Figure 7. Global Short Bowel Syndrome Market Size, by Glp-2, 2018-2026 (USD Million)
Figure 8. Global Short Bowel Syndrome Market Size, by Glp-2, by Region, 2020 vs 2026 (USD Million)
Figure 9. Global Short Bowel Syndrome Market Size, by Glutamine, 2018-2026 (USD Million)
Figure 10. Global Short Bowel Syndrome Market Size, by Glutamine, by Region, 2020 vs 2026 (USD Million)
Figure 11. Global Short Bowel Syndrome Market Size, by Growth Hormone, 2018-2026 (USD Million)
Figure 12. Global Short Bowel Syndrome Market Size, by Growth Hormone, by Region, 2020 vs 2026 (USD Million)
Figure 13. Global Short Bowel Syndrome Market Size, by Distribution Channel, 2020 vs 2026 (%)
Figure 14. Global Short Bowel Syndrome Market Size, by Distribution Channel, 2020 vs 2026 (USD Million)
Figure 15. Competitive Strategic Window for Global Short Bowel Syndrome Market Size, by Distribution Channel, 2026
Figure 16. Global Short Bowel Syndrome Market Size, by Hospital Pharmacies, 2018-2026 (USD Million)
Figure 17. Global Short Bowel Syndrome Market Size, by Hospital Pharmacies, by Region, 2020 vs 2026 (USD Million)
Figure 18. Global Short Bowel Syndrome Market Size, by Online Sales, 2018-2026 (USD Million)
Figure 19. Global Short Bowel Syndrome Market Size, by Online Sales, by Region, 2020 vs 2026 (USD Million)
Figure 20. Global Short Bowel Syndrome Market Size, by Retail Pharmacies, 2018-2026 (USD Million)
Figure 21. Global Short Bowel Syndrome Market Size, by Retail Pharmacies, by Region, 2020 vs 2026 (USD Million)
Figure 22. Americas Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 23. Argentina Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 24. Brazil Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 25. Canada Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 26. Mexico Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 27. United States Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 28. Asia-Pacific Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 29. Australia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 30. China Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 31. India Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 32. Indonesia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 33. Japan Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 34. Malaysia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 35. Philippines Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 36. Singapore Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 37. South Korea Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 38. Taiwan Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 39. Thailand Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 40. Europe, Middle East & Africa Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 41. France Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 42. Germany Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 43. Italy Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 44. Netherlands Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 45. Qatar Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 46. Russia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 47. Saudi Arabia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 48. South Africa Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 49. Spain Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 50. United Arab Emirates Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 51. United Kingdom Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Figure 52. Global Short Bowel Syndrome Market: FPNV Positioning Matrix
Figure 53. Global Short Bowel Syndrome Market: Share, by Key Player, 2020
Figure 54. Competitive Scenario Analysis in Global Short Bowel Syndrome Market, by Type

List of Tables
Table 1. Global Short Bowel Syndrome Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 4. Global Short Bowel Syndrome Market Size, by Drug Class, 2018-2026 (USD Million)
Table 5. Global Short Bowel Syndrome Market Size, by Glp-2, by Region, 2018-2026 (USD Million)
Table 6. Global Short Bowel Syndrome Market Size, by Glutamine, by Region, 2018-2026 (USD Million)
Table 7. Global Short Bowel Syndrome Market Size, by Growth Hormone, by Region, 2018-2026 (USD Million)
Table 8. Global Short Bowel Syndrome Market Size, by Distribution Channel, 2018-2026 (USD Million)
Table 9. Global Short Bowel Syndrome Market Size, by Hospital Pharmacies, by Region, 2018-2026 (USD Million)
Table 10. Global Short Bowel Syndrome Market Size, by Online Sales, by Region, 2018-2026 (USD Million)
Table 11. Global Short Bowel Syndrome Market Size, by Retail Pharmacies, by Region, 2018-2026 (USD Million)
Table 12. Americas Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 13. Argentina Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 14. Brazil Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 15. Canada Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 16. Mexico Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 17. United States Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 18. Asia-Pacific Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 19. Australia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 20. China Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 21. India Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 22. Indonesia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 23. Japan Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 24. Malaysia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 25. Philippines Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 26. Singapore Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 27. South Korea Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 28. Taiwan Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 29. Thailand Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 30. Europe, Middle East & Africa Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 31. France Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 32. Germany Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 33. Italy Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 34. Netherlands Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 35. Qatar Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 36. Russia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 37. Saudi Arabia Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 38. South Africa Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 39. Spain Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 40. United Arab Emirates Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 41. United Kingdom Short Bowel Syndrome Market Size, 2018-2026 (USD Million)
Table 42. Global Short Bowel Syndrome Market: Scores
Table 43. Global Short Bowel Syndrome Market: Business Strategy
Table 44. Global Short Bowel Syndrome Market: Product Satisfaction
Table 45. Global Short Bowel Syndrome Market: Ranking
Table 46. Global Short Bowel Syndrome Market: Share, by Key Player, 2020
Table 47. Global Short Bowel Syndrome Market: Merger & Acquisition
Table 48. Global Short Bowel Syndrome Market: Agreement, Collaboration & Partnership
Table 49. Global Short Bowel Syndrome Market: New Product Launch & Enhancement
Table 50. Global Short Bowel Syndrome Market: Investment & Funding
Table 51. Global Short Bowel Syndrome Market: Award, Recognition & Expansion
Table 52. Global Short Bowel Syndrome Market: License & Pricing
Note: Product cover images may vary from those shown
  • 9 Meters Biopharma, Inc.
  • Adocia SAS
  • Ardelyx Inc.
  • AstraZeneca PLC
  • Emmaus Life Sciences, Inc.
  • Merck KGaA
  • Nestlé S.A.
  • Novartis International AG
  • OPKO Health, Inc.
  • Oxthera AB
  • Pfizer Inc.
  • PhaseBio Pharmaceuticals Inc.
  • Sancilio and Company, Inc.
  • Swedish Orphan Biovitrum AB
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • VectivBio AG
  • Viatris Inc.
  • Zealand Pharma A/S
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll